glp-1 obesity drug news today oct 2025 2024 was a record year for trials and is already poised to take over GLP-1 RA Weight Loss Drugs
Description
Based on the encouraging efficacy of GLP-1/glucagon and GLP-1/GIP co-agonists, it was rationalized that a single molecule with triple agonism at all three of these receptors might provide even greater efficacy than the respective co-agonists
Some scientific research shows it can make us feel as if weve had enough to eat, which is great news for anyone trying to lose weight
107.Buse JB, Garber A, Rosenstock J, Schmidt WE, Brett JH, Videbaek N, Holst J, Nauck M
Leiter, S.P
FTC Crackdown on Telehealth Claims The FTC is taking action against telehealth firms using misleading prices, fake reviews, or deceptive weight loss claims, expanding oversight beyond medication to patient communications and marketing
GLP-1 medications address these challenges by: Reducing Appetite: They signal to the brain that youre full, helping you eat less naturally
